Treating COVID-19 patients in Taiwan with hydroxychloroquine, a drug commonly used to treat malaria, has not improved recovery times, the Central Epidemic Command Center (CECC) said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Science & Tech
AI 3D imaging system targets 29 medical centers by 2028: IntelliGen
10/05/2026 04:42 PM - Business
Taiex surges 1,200+ points to record high as Fed fears ease
10/05/2026 04:27 PM - Business
U.S. dollar closes lower on Taipei forex market
10/05/2026 04:17 PM - Politics
China pressured Munich institute to cancel Taiwan author event: Diplomat
10/05/2026 04:14 PM - Science & Tech
Metaverse healthcare can boost Taiwan's global competitiveness: Minister
10/05/2026 03:40 PM